PRLD — Prelude Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Prelude Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	291	202	233	134	103
Prepaid Expenses
Total Current Assets	295	204	236	136	106
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	5.64	6.7	37.7	35.5	32.3
Other Long Term Assets
Total Assets	305	221	278	176	141
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	19.2	21.7	21.8	25.6	53
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	19.2	25.1	40.6	44.1	72.7
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	286	195	237	131	68.6
Total Liabilities & Shareholders' Equity	305	221	278	176	141
Total Common Shares Outstanding